Optipharm, Vaccine/Diagnostic Reagents/Quarantine (H1N1, AI, etc.) Theme Rises 8.64% Up

On the 5th, the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) theme rose 3.36% compared to the previous day, showing strength, while Optipharm, a related stock attracting attention, surged 8.64% compared to the previous day.

[Graph] Major stock price changes in the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) theme



According to the analysis by Thinkpool Robo Algorithm RASSI, Optipharm’s quant financial score was 14.94 points, ranking 29th in the quant financial ranking within the vaccine/diagnostic reagent/quarantine (including novel flu, AI, etc.) related theme. This can be interpreted as Optipharm having relatively low investment attractiveness from a financial perspective. On the other hand, Kolmar Holdings ranked first in the quant financial ranking with higher growth, stability, and profitability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme


※ The quant financial score is the result of the Robo Algorithm analyzing each company’s sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist Thinkpool.

This content was produced with the assistance of AI translation services.